Agilvax is a private company that discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases.

Agilvax optimizes lead immunotherapy candidates through an extensive in vitro and in vivo testing process to ensure clinical efficacy. Immunotherapies with demonstrated clinical effectiveness are brought forward through pre-clinical and clinical testing. This process results in the development of effective and robust immunotherapies and vaccines that represent attractive out-licensing opportunities for Pharmaceutical and (or) Biotechnology partners.

Agilvax actively pursues and welcomes collaborations and partnerships with industry, academia, and government institutions.

We are looking to hire graduates in all degree types. Positions include: Research Scientists (molecular biology/cell culture background), Drug Development Expert, Clinical Trial Expert

Contact: Michael Perrine

mperrine@agilvax.com

(505) 604-1957

Website: www.agilvax.com